Inspire Investing LLC Decreases Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

Inspire Investing LLC lowered its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 14.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,217 shares of the medical instruments supplier’s stock after selling 1,761 shares during the period. Inspire Investing LLC’s holdings in West Pharmaceutical Services were worth $3,366,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. Norges Bank purchased a new position in West Pharmaceutical Services in the fourth quarter valued at about $300,250,000. Artisan Partners Limited Partnership raised its holdings in shares of West Pharmaceutical Services by 23.2% during the 4th quarter. Artisan Partners Limited Partnership now owns 1,961,063 shares of the medical instruments supplier’s stock valued at $690,530,000 after buying an additional 369,792 shares during the period. APG Asset Management US Inc. purchased a new stake in shares of West Pharmaceutical Services during the fourth quarter valued at approximately $88,227,000. LGT Group Foundation acquired a new position in shares of West Pharmaceutical Services during the second quarter worth $68,854,000. Finally, Liontrust Investment Partners LLP purchased a new position in shares of West Pharmaceutical Services in the second quarter valued at $64,196,000. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Insider Buying and Selling at West Pharmaceutical Services

In other news, VP Charles Witherspoon sold 1,029 shares of the stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the transaction, the vice president now owns 1,478 shares of the company’s stock, valued at $443,400. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.53% of the stock is currently owned by corporate insiders.

West Pharmaceutical Services Price Performance

WST opened at $309.20 on Thursday. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. The firm has a market cap of $22.43 billion, a price-to-earnings ratio of 40.79, a PEG ratio of 10.58 and a beta of 1.01. The company has a fifty day simple moving average of $304.36 and a 200 day simple moving average of $338.16.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). The business had revenue of $702.10 million for the quarter, compared to analysts’ expectations of $729.36 million. West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The firm’s revenue was down 6.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.11 earnings per share. Equities research analysts expect that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current fiscal year.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.